FIELD: medicine, experimental occupational pathology.
SUBSTANCE: in modeling the chronic fluorine osteopathy created by every day administration of sodium fluoride with drinking water in the dose 3.5 mg/kg method involves simultaneous administration of biologically active supplement "ALKA-Mine" in the dose 2-4 mg/kg of body mass of experimental animal. Method provides decreasing degradation of osseous tissue and elimination of fluorine from body based on optimal mineral composition of biologically active supplement proposed. Invention can be used in prophylaxis of chronic fluorine osteopathy.
EFFECT: improved method of prophylaxis.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION OF CHRONIC FLUORINE INTOXICATION IN EXPERIMENT SIMULATION | 2018 |
|
RU2673488C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| METHOD OF TREATING PATIENTS WITH ATROPHY OF ALVEOLAR PART OR DENTAL PROCESS IN OSTEOPENIC SYNDROME | 2008 |
|
RU2377012C1 |
| AGENT FOR LOW-TURNOVER METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2491940C1 |
| METHOD OF TREATING OSTEOPENIC SYNDROME IN POSTMENOPAUSAL OBESITY WOMEN | 2017 |
|
RU2698269C2 |
| METHOD FOR PREVENTING OSTEOPOROSIS IN MALE PATIENTS DISTINGUISHED BY PARTIAL ANDROGEN AGE-SPECIFIC DEFICIENCY (PADAM) | 2002 |
|
RU2236174C2 |
| METHOD OF PREDICTION OF HIP REPLACEMENT RESULTS | 2008 |
|
RU2373539C1 |
| METHOD OF TREATMENT OF OSTEOPOROSIS IN WOMEN IN POSTMENOPAUSE AGAINST THE BACKGROUND OF OBESITY | 2017 |
|
RU2657789C1 |
| METHOD OF SUBSTANTIATING THE OCCURRENCE IN CHILDREN OF A NEGATIVE EFFECT IN THE FORM OF A DISEASE OF THE SKELETAL SYSTEM ASSOCIATED WITH THE AEROGENIC EFFECT OF FLUORINE COMPOUNDS | 2017 |
|
RU2670769C1 |
| METHOD FOR EVALUATING INTEGRATION OF BONE REPLACEMENT MATERIAL IN EXPERIMENT | 2019 |
|
RU2715283C1 |
